English | Español

Boehringer Ingelheim
Robert Hadley | Jun 28, 2017

Pradaxa study highlights need for early diagnosis of atrial fibrillation
Ruth de Jauregui | Jun 2, 2017

Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients
Ruth de Jauregui | May 31, 2017

Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients
Gene Johnson | Mar 10, 2017

Boehringer Ingelheim, Vanderbilt University partner to expand cancer research
Carol Ostrow | Nov 27, 2016

‘Sweetheart’ survey reveals need for health education among type 2 diabetes patients
Amanda Rupp | Oct 2, 2016

Boehringer Ingelheim partners with ViraTherapeutics for immuno-oncology project
Amanda Rupp | Sep 6, 2016

Experts develop largest IPF patient registry yet

Trending
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval